Skip to main content

Table 2 Demographic and disease information a

From: Development and validation of a questionnaire to assess delay in treatment for breast cancer

 

Pretest 1

Pretest 2

Pretest 3

Test

 

(n=43)

(n=50)

(n=125)

(n=384)

Age (years)

  Mean (SD, range)

47.51 (12.29, 27–78)

51.08 (11.96, 28–81)

50.96 (12.12, 28–86)

49.61 (12.85, 18–91)

Marital status

  Married or living together

23 (54)

33 (66)

69 (55)

216 (56)

  Other

20 (46)

17 (34)

56 (45)

168 (44)

School education

  Analphabet

4 (9)

5 (10)

15 (12)

28 (7)

  6 years or less

20 (46)

25 (50)

42 (34)

134 (35)

  Between 7 and 9 years

11 (26)

13 (26)

27 (21)

92 (24)

  More than 9 years

8 (19)

7 (14)

41 (33)

130 (34)

Occupation

  Housewife

28 (65)

26 (52)

60 (48)

222 (58)

  Informal employment

NA

18 (36)

48 (38)

130 (34)

  Formal employment

NA

6 (12)

17 (14)

32 (8)

Monthly family income

  3 minimum wages or less

NA

39 (78)

89 (71)

243 (63)

  More than 3 minimum wages

NA

10 (20)

24 (19)

79 (25)

  Did not respond

NA

1 (2)

12 (10)

45 (12)

Means of problem detection

  Patient self discovery

38 (88)

43 (86)

101 (81)

297 (77)

  Screening CBE or mammogram

5 (12)

7 (14)

24 (19)

87 (23)

Final diagnosis

  Benign disease

11 (26)

7 (14)

24 (19)

117 (30)

  Cancer

31 (72)

43 (86)

98 (79)

259 (68)

  Unconfirmed

1 (2)

0

3 (2)

8 (2)

Cancer stage

  Stage 0 & I

1 (3)

4 (8)

12 (12)

35 (14)

  Stage II

12 (39)

22 (44)

37 (38)

86 (33)

  Stage III

12 (39)

12 (24)

35 (36)

90 (34)

  Stage IV

5 (16)

4 (8)

14 (14)

34 (13)

  Unknown

1 (3)

8 (16)

0

14 (6)

Delay intervals (days): median (IQR)

  Total interval

272.50 (391.50)

255.00 (402.00)

261.00 (403.00)

234.50 (361.00)

  Patient interval

30.00 (318.00)

23.00 (86.75)

14.00 (79.00)

11.00 (84.00)

  Provider interval

136.50 (199.75)

135.00 (406.00)

167.00 (284.00)

141.00 (213.00)

  1. a Values are number (%) unless specified; NA Not Available, CBE Clinical Breast Exam, IQR Interquartile Range.